Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Ribonucleic Acid (RNA) Sequencing Market Today And What Is Its Future Size?

The market for ribonucleic acid (rna) sequencing has seen an incredible expansion in past years. The forecast predicts a growth from $3.25 billion in 2024 to $3.96 billion in 2025, implying a compound annual growth rate (CAGR) of 21.8%. The significant growth during the previous years can be connected to increased drug development activities, higher incidence of genetic disorders and target diseases, an upsurge in the utilization of small-sized portable instruments, growing application of biomarker profiling, increasing demand for customized medicine, as well as a rise in the number of cancer cases.

Anticipated to witness a substantial surge over the coming years, the size of the ribonucleic acid (RNA) sequencing market is projected to clock in at $8.34 billion by 2029, with a compound annual growth rate (CAGR) of 20.5%. Factors propelling this growth within the projected timeframe include the escalating demand for quick and precise disease diagnosis, the increased implementation of real-time polymerase chain reaction, and the rising requirement for quick, on-site diagnostic tests, along with increases in disease outbreaks and the demand for companion diagnostics. Among the key trends that will define this forecast period are disease tracking and detection, drug discovery, verifying targets, identifying biomarkers, progress in DNA sequencing technology, advancements in diagnostic tests, the evolving next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and the development of cutting-edge molecular diagnostic solutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

Which Key Factors Are Fueling Growth In The Ribonucleic Acid (RNA) Sequencing Market?

The escalating emphasis on precision medicine is likely to fuel the expansion of the ribonucleic acid (RNA) sequencing market in the future. This progressive method of medical prevention and treatment takes into account the unique genetic, environmental, and lifestyle factors of each person. With the possibility of contributing to more efficacious treatments, the rise in genomic advancements, increase in disease complexity and regulatory backing, personalized medicine is becoming increasingly important. RNA sequencing methods play a crucial role in identifying and quantifying the expression levels of RNA molecules in a sample, providing a thorough analysis of transcriptomes, and offering insights into gene expression trends, alternative splicing occurrences, and RNA alterations. For example, in February 2024, as reported by the Personalized Medicine Coalition, a non-profit organization based in the US, 16 innovative personalized therapies for patients suffering from unusual diseases were sanctioned by the FDA in 2023, signifying a notable increase from the six that were authorized in 2022. As a result, the rising emphasis on precision medicine is fostering the growth of the ribonucleic acid (RNA) sequencing market.

How Is The Ribonucleic Acid (RNA) Sequencing Market Segmented Across Key Categories?

The ribonucleic acid (rna) sequencingmarket covered in this report is segmented –

1) By Product Type: Instruments; Reagents And Kits; Software

2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications

4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits

3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software

What Current And Upcoming Trends Are Shaping The Ribonucleic Acid (RNA) Sequencing Market?

Leading businesses in the RNA sequencing market are prioritizing RNA next-generation sequencing assay in their operations. This approach aims to enhance patient care by offering data-driven insights and precision-based medicine. Using advanced genomic sequencing technologies, RNA next-generation sequencing assay allows for the complete analysis of a patient’s exome. For instance, Tempus, a precision medicine technology company from the US, launched its unique RNA next-generation sequencing assay called ‘Tempus xR’ in June 2023. This new assay is specifically tailored for solid tumors and enables a comprehensive review of the entire transcriptome. It can identify clinically significant fusions in over 100 targeted genes and modified splicing for MET Exon 14 and EGFRvIII. As a result, Tempus xR is particularly useful for physicians interested in RNA fusions or modified splicing, as well as providers, researchers, and biopharma companies who require detailed RNA sequencing analysis of available samples.

Who Are The Leading Companies Driving The Ribonucleic Acid (RNA) Sequencing Market?

Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Which Region Dominates The Ribonucleic Acid (RNA) Sequencing Market Today?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp

Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Sequencing Market 2025, By The Business Research Company

Induction Furnace Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/induction-furnace-global-market-report

Alternative Fuel Vehicles Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alternative-fuel-vehicles-global-market-report

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model